Stammdaten
Unternehmen
| Name | Tenaya Therapeutics, Inc. |
|---|---|
| Ticker | TNYA |
| CIK | 0001858848 |
Branche
| SIC-Code | 2836 |
|---|---|
| Beschreibung | Biological Products, (No Diagnostic Substances) |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Tenaya Therapeutics, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:38:09.117369 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-25 | COLUMN GROUP III GP, LP | 10% Owner | Open Market Sale | -1,862,545 | 0.56 | -1,047,495.31 | -299,3% | |
| 2026-02-25 | COLUMN GROUP III GP, LP | 10% Owner | Open Market Sale | -1,649,281 | 0.56 | -927,555.63 | -265,0% | |
| 2026-02-24 | COLUMN GROUP III GP, LP | 10% Owner | Open Market Sale | -309,228 | 0.62 | -190,267.99 | -54,4% | |
| 2026-02-24 | COLUMN GROUP III GP, LP | 10% Owner | Open Market Sale | -349,212 | 0.62 | -214,870.14 | -61,4% | |
| 2026-02-23 | COLUMN GROUP III GP, LP | 10% Owner | Open Market Sale | -143,709 | 0.60 | -85,823.01 | -24,5% | |
| 2026-02-23 | COLUMN GROUP III GP, LP | 10% Owner | Open Market Sale | -162,291 | 0.60 | -96,920.19 | -27,7% | |
| 2026-02-20 | COLUMN GROUP III GP, LP | 10% Owner | Open Market Sale | -277,769 | 0.61 | -170,800.16 | -48,8% | |
| 2026-02-20 | COLUMN GROUP III GP, LP | 10% Owner | Open Market Sale | -245,965 | 0.61 | -151,243.88 | -43,2% | |
| 2026-02-11 | COLUMN GROUP III GP, LP | 10% Owner | Open Market Sale | -2,151,458 | 0.68 | -1,464,712.61 | -418,5% | |
| 2026-02-11 | COLUMN GROUP III GP, LP | 10% Owner | Open Market Sale | -1,905,115 | 0.68 | -1,297,002.29 | -370,6% | |
| 2026-02-10 | COLUMN GROUP III GP, LP | 10% Owner | Open Market Sale | -161,422 | 0.82 | -131,736.49 | -37,6% | |
| 2026-02-10 | COLUMN GROUP III GP, LP | 10% Owner | Open Market Sale | -182,295 | 0.82 | -148,770.95 | -42,5% | |
| 2025-08-18 | Tingley Whittemore | Officer, Chief Medical Officer | Open Market Sale | -1,837 | 1.25 | -2,301.76 | -0,7% | |
| 2025-08-18 | Ali Faraz | Director, Officer, Chief Executive Officer | Open Market Sale | -3,893 | 1.25 | -4,877.93 | -1,4% | |
| 2025-08-18 | Ali Faraz | Director, Officer, Chief Executive Officer | Open Market Sale | -4,920 | 1.25 | -6,164.76 | -1,8% | |
| 2025-08-18 | Tingley Whittemore | Officer, Chief Medical Officer | Open Market Sale | -1,608 | 1.25 | -2,014.82 | -0,6% | |
| 2025-08-18 | Ali Faraz | Director, Officer, Chief Executive Officer | Open Market Sale | -5,720 | 1.25 | -7,167.16 | -2,0% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.